A machine learning algorithm successfully screens for Parkinson's in web users.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
12 2019
Historique:
received: 10 10 2019
accepted: 21 10 2019
pubmed: 13 11 2019
medline: 2 10 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

To develop, apply, and evaluate, a novel web-based classifier for screening for Parkinson disease among a large cohort of search engine users. A supervised machine learning classifier learned to distinguish web users with self-reported Parkinson's disease from controls based on their interactions with a search engine (Bing, Microsoft). It was then applied to groups of web users with low or high risk for actual Parkinson's disease. Textual content of web queries was used to sort surfers into the different risk groups, but not for classifying users as negative or positive for Parkinson's disease. Disease detection was unsolicited. Researchers did not have access to any identifying data on users. Applying the classifier (with an estimated positive predictive value of 25%) resulted in 17,843/1,490,987 (1.2%) web users over the age of 40 years screened positive for Parkinson's disease. This percentile was higher in at-risk groups (Fisher exact P < 0.00001), including users who searched for information regarding the disease (518/804, 64.4%), and users with non-motor Parkinson's symptom or with an affected relative (57/1064, 5.3%). Longitudinal follow-up revealed that in all studied groups individuals classified as having the disease showed a higher mean rate of progression in disease-related features (t-test P < 0.05). An automatic classifier, based on mouse and keyboard interactions with a search engine, is able to reliably trace individuals at high risk for actual Parkinson's disease as well as to demonstrate more rapid progression of disease-related signs in those who screened positive. This ability raises novel ethical issues.

Identifiants

pubmed: 31714022
doi: 10.1002/acn3.50945
pmc: PMC6917308
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2503-2509

Informations de copyright

© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

Références

Arch Intern Med. 2011 Mar 28;171(6):487-8
pubmed: 21444838
Lancet Neurol. 2006 Jun;5(6):525-35
pubmed: 16713924
Arch Neurol. 1997 Aug;54(8):937-44
pubmed: 9267967
Eur J Hum Genet. 2016 Jan;24(1):21-9
pubmed: 25920556
PLoS One. 2017 Nov 30;12(11):e0188226
pubmed: 29190695
Mov Disord. 2017 Feb;32(2):219-226
pubmed: 28090684
Sci Rep. 2018 May 16;8(1):7663
pubmed: 29769594
IEEE Trans Biomed Eng. 2017 Sep;64(9):1994-2002
pubmed: 28237917
Sci Rep. 2016 Oct 05;6:34468
pubmed: 27703257
NPJ Digit Med. 2018 Apr 23;1:8
pubmed: 31304293
PLoS Negl Trop Dis. 2011 Aug;5(8):e1258
pubmed: 21829744
Mov Disord. 2015 Oct;30(12):1600-11
pubmed: 26474317
J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):10-5
pubmed: 9010393
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Nature. 2009 Feb 19;457(7232):1012-4
pubmed: 19020500
Nat Clin Pract Neurol. 2009 Mar;5(3):136-7
pubmed: 19174773
JAMA Oncol. 2017 Mar 1;3(3):398-401
pubmed: 27832243
BMJ. 1999 Jan 23;318(7178):251-3
pubmed: 9915739
JAMA. 1993 Nov 24;270(20):2444-50
pubmed: 8230621
J Oncol Pract. 2016 Aug;12(8):737-44
pubmed: 27271506
J Am Med Inform Assoc. 2013 May 1;20(3):404-8
pubmed: 23467469
Bioethics. 2018 Mar;32(3):193-198
pubmed: 29369379
Neurology. 2016 Feb 9;86(6):566-76
pubmed: 26764028
Neurology. 1995 Dec;45(12):2143-6
pubmed: 8848182
Nat Commun. 2013;4:2837
pubmed: 24302074
J Med Internet Res. 2015 Jan 27;17(1):e29
pubmed: 25626480
Am J Prev Med. 2011 Apr;40(4):448-53
pubmed: 21406279

Auteurs

Brit Youngmann (B)

Microsoft Research, Herzliya, Israel.

Liron Allerhand (L)

Microsoft Research, Herzliya, Israel.

Ora Paltiel (O)

Braun School of Public Health and Community Medicine, Hadassah-Hebrew University, Jerusalem, Israel.

Elad Yom-Tov (E)

Microsoft Research, Herzliya, Israel.
Faculty of Industrial Engineering and Management, Technion, Haifa, Israel.

David Arkadir (D)

Department of Neurology, Hadassah Hebrew University, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH